The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Support COVID-19 Research

Publication

< Back to Publications Listing

ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction


Author(s):

Tomomi Kawakita, Toshiki Sekiya, Yayoi Kameda, Naoki Nomura, Marumi Ohno, Chimuka Handabile, Akari Yamaya, Hideo Fukuhara, Yuki Anraku, Shunsuke Kita, Shinsuke Toba, Hirotake Tsukamoto, Tomohiro Sawa, Hiroyuki Oshiumi, Yasushi Itoh, Katsumi Maenaka, Akihiko Sato, Hirofumi Sawa, Yasuhiko Suzuki, Lorena E. Brown, David C. Jackson, Hiroshi Kida, Misako Matsumoto, Tsukasa Seya, Masashi Shingai

Details:

Journal of virology, Volume 99, Issue 5, 2025-05-20

Article Link: Click here

Affiliations:

  • Hokkaido University
  • Graduate School of Medical Sciences
  • Graduate School of Medicine
  • Graduate School of Medicine
  • The Peter Doherty Institute for Infection and Immunity
  • Aomori University
  • Shionogi & Co., Ltd.
  • Shiga University of Medical Science

Contact Us

792 Elizabeth Street
Melbourne, 3000
Get Directions

doherty-reception@unimelb.edu.au
+61 3 9035 3555
Contact Us

Keep informed

Subscribe for the latest news, events and research

We acknowledge the Wurundjeri people of the Kulin Nation as the traditional custodians of the land where our Institute stands.

We are committed to collaboration with Aboriginal and Torres Strait Islander communities to reduce the unacceptable burden of infectious disease. We are committed to training the next generation of exceptional Indigenous leaders in infection and immunity.

Copyright The Peter Doherty Institute for Infection and Immunity
Privacy Policy | Intranet | Site by Lemonade